With the emergence of new patient care pathways, the growth of point-of-care testing has been driven by new technology. This has offered patients improved health outcomes, utilising diagnostics and solutions that help relieve the pressures on our health system.
Una Health is a leading independent UK provider of diagnostics for the laboratory and point of care. The company’s vision is to transform patient pathways and improve health outcomes, utilising diagnostics and solutions that help relieve the pressures on our health system.
Established in 2009, the company’s aim was simple – to help to provide the best service possible for customers at an affordable cost and with the upmost flexibility. Over 15 years, its partnerships with industry leaders have grown, as have its carefully curated product solutions, backed by a team with extensive experience in the diagnostics industry.
One of the first products distributed was the OPTI Blood Gas and Electrolyte Analyser, a point-of-care testing (POCT) device, so near-patient testing has always been at the core of what Una Health does. Point-of-care testing has been around for around 50 years, initially focusing on simple tests such as glucose monitoring. However, it has been in the past decade – accelerated by the COVID-19 pandemic – that it has really taken off, with POCT now expanding to a wide range of biomarkers.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.